Monte Rosa Therapeutics (GLUE) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $28.1 million.
- Monte Rosa Therapeutics' Other Gross PP&E Adjustments rose 2535.52% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 2535.52%. This contributed to the annual value of $23.0 million for FY2024, which is 3351.12% up from last year.
- As of Q3 2025, Monte Rosa Therapeutics' Other Gross PP&E Adjustments stood at $28.1 million, which was up 2535.52% from $26.8 million recorded in Q2 2025.
- Monte Rosa Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $28.1 million for Q3 2025, and its period low was $13.5 million during Q2 2023.
- In the last 3 years, Monte Rosa Therapeutics' Other Gross PP&E Adjustments had a median value of $21.6 million in 2024 and averaged $20.7 million.
- As far as peak fluctuations go, Monte Rosa Therapeutics' Other Gross PP&E Adjustments surged by 5920.97% in 2024, and later skyrocketed by 2340.17% in 2025.
- Quarter analysis of 3 years shows Monte Rosa Therapeutics' Other Gross PP&E Adjustments stood at $17.2 million in 2023, then soared by 33.51% to $23.0 million in 2024, then increased by 21.9% to $28.1 million in 2025.
- Its Other Gross PP&E Adjustments was $28.1 million in Q3 2025, compared to $26.8 million in Q2 2025 and $24.4 million in Q1 2025.